Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Boceprevir

SKU: orb1302390

Description

Boceprevir is a potent and selective oral inhibitor of the HCV NS3 protease, exhibiting a Ki of 14 nM in enzymatic assays and an EC90 of 350 nM in cellular replicon systems. It has been utilized in both in vitro and in vivo research to study hepatitis C virus replication and protease inhibitor mechanisms.

Research Area

Immunology & Inflammation

Images & Validation

Key Properties

CAS Number394730-60-0
MW519.7
Purity>98%
FormulaC27H45N5O5
SMILESC(NC(CC1CCC1)C(C(N)=O)=O)(=O)[C@@H]2[C@@]3([C@@](C3(C)C)(CN2C([C@@H](NC(NC(C)(C)C)=O)C(C)(C)C)=O)[H])[H]
TargetProtease
SolubilitySoluble in DMSO (up to at least 15 mg/ml); or Ethanol (25 mg/ml)

Bioactivity

Target IC50
HCV NS3 protease:14nM(Ki)
In Vivo
Boceprevir is a chemical compound designed as an HCV Protease Inhibitor for treating Hepatitis C Virus Infection. Its pharmacokinetic properties have been assessed across different animal species. Following oral administration, Boceprevir exhibits moderate absorption in rats (10 mg/kg), dogs (3 mg/kg), and monkeys (3 mg/kg), with absorption being relatively quicker in dogs compared to slower rates in mice (10 mg/kg), rats, and monkeys, as indicated by mean absorption times (MAT) of 0.5 to 1.4 hours. The compound demonstrates effective area under the curve (AUC) values in dogs and rats, moderate values in mice, and lower values in monkeys. Its absolute oral bioavailability ranges from modest (26-34%) in mice, rats, and dogs, to low (4%) in monkeys. Additionally, Boceprevir, at a dosage of 100 mg/kg orally, effectively inhibits HCV NS3/4A protease activity in triple-transgenic mice.
In Vitro
In the HCV NS3 protease continuous assay, Boceprevir (SCH 503034) has a potency of 14 nM (Ki) average over a large number of runs. In the 72-h bicistronic subgenomic cell-based replicon assay in HuH-7 cells, the EC50 and EC90 values are determined to be 0.20 μM and 0.35 μM, respectively. Boceprevir is also found to be a very weak inhibitor of HNE (Ki=26 μM) representing a selectivity of 2200.

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

SCH 503034

Similar Products

  • Boceprevir [orb1225120]

    >98% (HPLC)

    394730-60-0

    519.6767

    C27H45N5O5

    5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 200 mg, 500 mg, 1 g
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Protocol Information

Available Sizes

Select a size below

5 mg
$ 200.00
25 mg
$ 410.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry